GE HEALTHC.TECH.INC. -,01
75,72€
+0,03 (+0,04%)
08.05.2024, 22:59:50 Uhr
WKN: A3D3G6 ISIN: US36266G1076 Wertpapiertyp: Aktie Währung: Euro
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Weltmärkte
- DAX ® +68,33 +0,37% 18.498,38
- MDAX ® +133,86 +0,50% 26.695,33
- TecDAX ® -8,75 -0,26% 3.350,46
- E-STOXX 50 ® +22,07 +0,44% 5.038,17
- NASDAQ 100 -6,43 -0,04% 18.085,01
- NIKKEI -419,06 -1,08% 38.292,16
- HANG SENG +205,83 +1,12% 18.519,69
Kursperformance
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Tag | 75,72€ | +0,04% |
| 1 Woche | 71,54€ | +5,80% |
| 1 Monat | 81,42€ | -7,04% |
| 6 Monate | 65,95€ | +14,77% |
| Lfd. Jahr (YTD) | 69,45€ | +8,99% |
| 1 Jahr | 71,86€ | +5,33% |
| 3 Jahre | -- | -- |
| 5 Jahre | -- | -- |
Kursdaten
| Kurs | 75,72€ |
| Eröffnung | 75,15€ |
| Geld | 75,06€ |
| Brief | 75,65€ |
| Tages-Hoch | 75,72€ |
| Tages-Tief | 75,15€ |
| 52 Wochen-Hoch | 86,00€ |
| 52 Wochen-Tief | 59,50€ |
| Allzeit-Hoch | 86,00€ |
| Allzeit-Tief | 54,30€ |
Nachrichten
- BUSINESS WIRE: GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies - 02.11.2023, 13:00:09 Uhr
- BUSINESS WIRE: SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers - 11.10.2023, 14:00:54 Uhr
- BUSINESS WIRE: First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies - 15.06.2023, 08:00:06 Uhr
